2016
DOI: 10.2147/ccid.s89483
|View full text |Cite
|
Sign up to set email alerts
|

Management of familial benign chronic pemphigus

Abstract: Benign familial chronic pemphigus or Hailey–Hailey disease is caused by an autosomal dominant mutation in the ATP2C1 gene leading to suprabasilar acantholysis. The disease most commonly affects intertriginous areas symmetrically. The chronic nature of the disease and multiple recurrences make the disease bothersome for patients and a treatment challenge for physicians. Treatments include topical and/or systemic agents and surgery including laser. This review summarizes the available treatment options.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
31
0
2

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 42 publications
(33 citation statements)
references
References 64 publications
0
31
0
2
Order By: Relevance
“…First-line treatment for Hailey-Hailey disease is topical and should include a topical corticosteroid with or without a topical antimicrobial. 1,2 Hailey-Hailey disease can have an appearance similar to that of acanthosis nigricans in dark-skinned patients, but acanthosis nigricans is typically asymptomatic and unlikely to vary with season. A crusted rash with seasonal variation could suggest seborrheic dermatitis or candidal intertrigo, which can be treated with ketoconazole.…”
Section: Discussionmentioning
confidence: 99%
“…First-line treatment for Hailey-Hailey disease is topical and should include a topical corticosteroid with or without a topical antimicrobial. 1,2 Hailey-Hailey disease can have an appearance similar to that of acanthosis nigricans in dark-skinned patients, but acanthosis nigricans is typically asymptomatic and unlikely to vary with season. A crusted rash with seasonal variation could suggest seborrheic dermatitis or candidal intertrigo, which can be treated with ketoconazole.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, patients develop lesions refractory to corticosteroids. As lesions became recalcitrant to SOC treatment, several possible treatments have been proposed, including: Botulinum toxin injection and photodynamic therapy [ 8 ]. However, evidence for the above indicated treatments of HHD is limited to case reports, case series, and expert opinion.…”
Section: Introductionmentioning
confidence: 99%
“…Immunotherapy', Institut de Recherche Saint Louis, Paris, France; 3 Universit e de Paris, Paris, France; 6 Hematology Laboratory, Saint Louis Hospital, Paris, France; 7 EA3518, Saint Louis Hospital, Paris, France; and 8 Patients affected by HHD typically present between the third and fourth decades of life with disease predominantly affecting intertriginous areas including the lateral aspects of the neck, axillae, umbilicus, inguinal and perianal areas. 2 We describe a case series of three patients with recalcitrant HHD whose clinical findings and symptoms significantly improved with dupilumab.…”
mentioning
confidence: 99%
“…Acknowledgments: we would like to thank the patients enrolled in the present study. C. Zimmermann, 1,2,3 M. Boisson, 4 C. Ram-Wolff, 1 A. Sadoux, 4 B. Louveau iD , 2,3,4 M.-D. Vignon-Pennamen, 5 J. Rivet, 5 J.-M. Cayuela, 3,6,7 G. Dobos, 1,2,3 H. Moins-Teisserenc iD , 3,6,8 M. Roelens, 3,8 A. Gruber, 4 C. Lebb e, 1,2,3 M. Bagot iD , 1,2,3 M. Battistella, 2,3,5 S. Mourah 2,3,4 and A. de Masson iD 1,2,3 Acknowledgments: we would like to thank the Pfizer Inflammatory and Immune-mediated Skin Diseases Fellowship. N. Alzahrani iD , 1 J. Grossman-Kranseler, 2 R. Swali iD , 3 K. Fiumara, 4 P. Zancanaro, 2 S. Tyring 5…”
mentioning
confidence: 99%
See 1 more Smart Citation